GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Names Health Tech Pioneer Taha Kass-Hout First Chief Technology Officer

GE HealthCare (Nasdaq: GEHC) announced today that Taha Kass-Hout MD, MS has been named Chief Technology Officer (CTO) to lead the company’s new science and technology organization. The new group, alongside the creation of the CTO role, demonstrates GE HealthCare’s commitment to driving innovation, growth, and value through research and development.

Reporting into GE HealthCare President & CEO Peter Arduini, Dr. Kass-Hout will help drive GE HealthCare’s D3 precision care strategy, a framework and digital products that emphasize the company’s smart devices, aligned to disease states and enabled by digital. D3 brings data and insights together to optimize the clinical and patient journey and enhances the company's ability to enable precision care.

In his new role, Dr. Kass-Hout will work in partnership with GE HealthCare’s four business segments (Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics), regions, and global engineering and machine learning (ML) teams to drive growth through clinical research, patient-centric innovation and advancements to GE HealthCare’s platforms, and digital and ML capabilities.

An industry and digital leader, on a recently updated U.S. Food and Drug Administration (FDA) list of artificial intelligence (AI) enabled medical devices, GE HealthCare had the highest number of authorizations, with 42 listed clearances to date. GE HealthCare AI-enabled products include , an MRI deep-learning-based solution that can scan patients in half the time of a conventional scan while also improving image quality; , an industry-first collection of AI algorithms embedded on a mobile x-ray device for case prioritization, automated measurements, and quality control; and , a Women’s Health ultrasound system that provides improved image quality and specialized clinical tools to help see more anatomical detail with greater certainty and support excellent patient care.

Prior to joining GE HealthCare, Dr. Kass-Hout served as Vice President, Machine Learning and Chief Medical Officer Amazon and Amazon Web Services. In that role, Dr. Kass-Hout established and led Health AI strategy and technologies, including Amazon HealthLake, Amazon Comprehend Medical, and Amazon Omics, for health care, genomics, and life sciences industries. He also served two terms in the Obama Administration as the FDA’s first Chief Health Informatics Officer, and Director, Information Science and Informatics for the U.S. Centers for Disease Control and Prevention.

The new science and technology organization will work to execute GE HealthCare’s common goal of advancing the future of healthcare by delivering personalized care across the patient journey to improve patient outcomes and increase productivity for customers.

“GE HealthCare has a strong track record of industry-first technologies and an innovation pipeline of products focused on improving patient care,” said Peter Arduini, GE HealthCare President and CEO. “As a cardiologist, digital and ML expert, Taha has exceptional clinical and technology experience. Under his leadership, our new science and research organization will drive greater end-to-end alignment within our key research and product development segments to deliver innovative solutions that transform the future of healthcare and enhance our ability to enable precision care.”

The new science and technology organization will be made up of researchers who innovate new technologies for the healthcare ecosystem; the digital organization that executes on digital strategies from software development to device integration and cloud adoption to help drive better clinical decision making and improve patient outcomes; and the region research teams who connect and execute the external engagement strategy and cultivate scientific mindshare and academic partnerships with GE HealthCare’s innovation strategy.

“As a clinician, public servant, and digital heath and ML expert, I am honored to join the GE HealthCare team, whose passion, purpose and commitment to lead the digital transformation and improve outcomes for patients and providers clearly aligns with mine,” said Taha Kass-Hout MD, MS, Chief Technology Officer, GE HealthCare. “I am excited about what lies ahead and the incredible opportunity to deliver on GE HealthCare’s purpose of creating a world where healthcare has no limits and establishing a new frontier in advancing diagnostics and personalized therapeutics to people.”

Dr. Kass-Hout will define and lead a customer-driven enterprise-wide innovation and clinical strategy, integrating the most pressing clinical priorities with a multi-year technology strategy focused on new product introductions that support care pathways, R&D investment prioritization and a team with diversity of thought and capabilities to fuel clinical advancements, growth, and innovation.

“One of the biggest dilemmas our customers face is delivering personalized care the right way, getting the right diagnosis with the right data,” said Arduini. “With our D3 precision care framework, GE HealthCare is uniquely positioned to help our customers leverage data across health care systems, to solve diagnosis challenges and develop personalized approaches for better patient outcomes, while increasing productivity.”

About GE HealthCare

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.

EN
05/01/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

Moody's Ratings assigns Baa2 rating to GE Healthcare's sr. notes; stab...

Moody's Ratings (Moody's) assigned a Baa2 rating to GE HealthCare Technologies Inc.'s ("GE HealthCare") proposed offering of senior unsecured notes. There are no changes to GE HealthCare's existing ratings including the Baa2 issuer rating, Baa2 senior unsecured notes ratings and (P)Baa2 senior unsec...

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch